Amgen Inc.
Dosing of KRAS inhibitor for treatment of cancers
Last updated:
Abstract:
Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
Status:
Grant
Type:
Utility
Filling date:
13 May 2020
Issue date:
30 Aug 2022